H11/HspB8 has antiapoptotic activity in glioblastoma and breast cancer cells through cell-cycle regulation, potentially involving activation of the growth-associated transcription factor E2F and/or the cyclin-dependent kinase cdk4. This evidence concerns the gene HSPB8 and breast cancer.